Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Hepatitis B virus X (HBx) protein has been reported as a key protein regulating the pathogenesis of HBV-induced hepatocellular carcinoma (HCC). Recent evidence has shown that HBx is implicated in the activation of autophagy in hepatic cells. Nevertheless, the precise molecular and cellular mechanism by which HBx induces autophagy is still controversial. Herein, we investigated the molecular and cellular mechanism by which HBx is involved in the TRAF6-BECN1-Bcl-2 signaling for the regulation of autophagy in response to TLR4 stimulation, therefore influencing the HCC progression. HBx interacts with BECN1 (Beclin 1) and inhibits the association of the BECN1-Bcl-2 complex, which is known to prevent the assembly of the pre-autophagosomal structure. Furthermore, HBx enhances the interaction between VPS34 and TRAF6-BECN1 complex, increases the ubiquitination of BECN1, and subsequently enhances autophagy induction in response to LPS stimulation. To verify the functional role of HBx in liver cancer progression, we utilized different HCC cell lines, HepG2, SK-Hep-1, and SNU-761. HBx-expressing HepG2 cells exhibited enhanced cell migration, invasion, and cell mobility in response to LPS stimulation compared to those of control HepG2 cells. These results were consistently observed in HBx-expressed SK-Hep-1 and HBx-expressed SNU-761 cells. Taken together, our findings suggest that HBx positively regulates the induction of autophagy through the inhibition of the BECN1-Bcl-2 complex and enhancement of the TRAF6-BECN1-VPS34 complex, leading to enhance liver cancer migration and invasion.
Abstract
Hepatitis B virus X (HBx) protein has been reported as a key protein regulating the pathogenesis of HBV-induced hepatocellular carcinoma (HCC). Recent evidence has shown that HBx is implicated in the activation of autophagy in hepatic cells. Nevertheless, the precise molecular and cellular mechanism by which HBx induces autophagy is still controversial. Herein, we investigated the molecular and cellular mechanism by which HBx is involved in the TRAF6-BECN1-Bcl-2 signaling for the regulation of autophagy in response to TLR4 stimulation, therefore influencing the HCC progression. HBx interacts with BECN1 (Beclin 1) and inhibits the association of the BECN1-Bcl-2 complex, which is known to prevent the assembly of the pre-autophagosomal structure. Furthermore, HBx enhances the interaction between VPS34 and TRAF6-BECN1 complex, increases the ubiquitination of BECN1, and subsequently enhances autophagy induction in response to LPS stimulation. To verify the functional role of HBx in liver cancer progression, we utilized different HCC cell lines, HepG2, SK-Hep-1, and SNU-761. HBx-expressing HepG2 cells exhibited enhanced cell migration, invasion, and cell mobility in response to LPS stimulation compared to those of control HepG2 cells. These results were consistently observed in HBx-expressed SK-Hep-1 and HBx-expressed SNU-761 cells. Taken together, our findings suggest that HBx positively regulates the induction of autophagy through the inhibition of the BECN1-Bcl-2 complex and enhancement of the TRAF6-BECN1-VPS34 complex, leading to enhance liver cancer migration and invasion.
참고문헌 (45)
- El-Serag HB, "Hepatocellular carcinoma : epidemiology and molecular carcinogenesis", Gastroenterology, 132, pp.2557~2576 (2007)
- Marra M, "Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma : an overview", J Transl Med, 9, pp.171~ (2011)
- Kew MC, "Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma", J Gastroenterol Hepatol, 26(Suppl 1), pp.144~152 (2011)
- Yang S, "New insights into autophagy in hepatocellular carcinoma : mechanisms and therapeutic strategies", Am J Cancer Res, 9, pp.1329~1353 (2019)
- Liu L, "The role of autophagy in hepatocellular carcinoma : friend or foe", Oncotarget, 8, pp.57707~57722 (2017)
- Huang F, "Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma", World J Gastroenterol, 24, pp.4643~4651 (2018)
- Cui J, "The role of autophagy in liver cancer: crosstalk in signaling pathways and potential therapeutic targets", Pharmaceuticals(Basel), 13, pp.432~ (2020)
- He C, "Regulation mechanisms and signaling pathways of autophagy", Annu Rev Genet, 43, pp.67~93 (2009)
- Ravikumar B, "Regulation of mammalian autophagy in physiology and pathophysiology", Physiol Rev, 90, pp.1383~1435 (2010)
- Funderburk SF, "The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond", Trends Cell Biol, 20, pp.355~362 (2010)
- Marquez RT, "Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy", apoptosis toggle switch, 2012, pp.2, 214~221
- Jiang GM, "The relationship between autophagy and the immune system and its applications for tumor immunotherapy", Mol Cancer, 18, pp.17~ (2019)
- Janji B, "The multifaceted role of autophagy in tumor evasion from immune surveillance", Oncotarget, 7, pp.17591~17607 (2016)
- Yang J, "Emerging role of Toll-like receptor 4 in hepatocellular carcinoma", J Hepatocell Carcinoma, 2, pp.11~17 (2015)
- Chung C, "Crosstalks between inflammasome and autophagy in cancer", J Hematol Oncol, 13, pp.100~ (2020)
- Wang Z, "Autophagy : a novel therapeutic target for hepatocarcinoma(Review)", Oncol Lett, 7, pp.1345~1351 (2014)
- Lopes JA, "Innate immunity and hepatocarcinoma : can toll-like receptors open the door to oncogenesis", World J Hepatol, 8, pp.162~182 (2016)
- Zhan Z, "Autophagy facilitates TLR4-and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination", Autophagy, 10, pp.257~268 (2014)
- Min Y, "Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation", Autophagy, 14, pp.1347~1358 (2018)
- Kim MJ, "p62 is Negatively Implicated in the TRAF6-BECN1 signaling axis for autophagy activation and cancer progression by Toll-like receptor 4(TLR4)", Cells, 9, pp.1142~ (2020)
- Kang R, "The Beclin 1 network regulates autophagy and apoptosis", Cell Death Differ, 18, pp.571~580 (2011)
- Morris DH, "Beclin 1-VPS34 complex architecture: understanding the nuts and bolts of therapeutic targets", Front Biol(Beijing), 10, pp.398~426 (2015)
- Maiuri MC, "Functional and physical interaction between Bcl-X(L)and a BH3-like domain in Beclin-1", EMBO J, 26, pp.2527~2539 (2007)
- Sir D, "The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication", Proc Natl Acad Sci U S A, 107, pp.4383~4388 (2010)
- Tang H, "Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression", Hepatology, 49, pp.60~71 (2009)
- Park S, "Suppression of hepatocyte nuclear factor 4 α by long-term infection of hepatitis B virus contributes to tumor cell proliferation", Int J Mol Sci, 21, pp.948~ (2020)
- Kim MJ, "AMPKα1 regulates lung and breast cancer progression by regulating TLR4-mediated TRAF6-BECN1 signaling axis", Cancers(Basel), 12, pp.3289~ (2020)
- 김미정, "p62 Negatively Regulates TLR4 Signaling via Functional Regulation of the TRAF6-ECSIT Complex", Immune Network, 19(3), pp.1~14 (2019), 대한면역학회
- Kim MJ, "CRBN is a negative regulator of bactericidal activity and autophagy activation through inhibiting the ubiquitination of ECSIT and BECN1", Front Immunol, 10, pp.2203~ (2019)
- Min Y, "Peroxiredoxin-6 negatively regulates bactericidal activity and NFκB activity by interrupting TRAF6-ECSIT complex", Front Cell Infect Microbiol, 7, pp.94~ (2017)
- Borowicz S, "The soft agar colony formation assay", J Vis Exp, 92, pp.e51998~ (2014)
- Franken NA, "Clonogenic assay of cells in vitro", Nat Protoc, 1, pp.2315~2319 (2006)
- Shi CS, "TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy", Sci Signal, 3, pp.ra42~ (2010)
- Decuypere JP, "Regulation of the autophagic bcl-2", beclin 1 interaction, 2012, pp.1, 284~312
- Gearhart TL, "The hepatitis B virus HBx protein modulates cell cycle regulatory proteins in cultured primary human hepatocytes", Virus Res, 155, pp.363~367 (2011)
- Wang P, "HBx induces HepG-2 cells autophagy through PI3K", Akt-mTOR pathway, 2013, pp.372, 161~168
- Kowalik MA, "Induction of autophagy promotes the growth of early preneoplastic rat liver nodules", Oncotarget, 7, pp.5788~5799 (2016)
- Huo X, "Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients", BMC Cancer, 20, pp.771~ (2020)
- Li J, "Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition", Carcinogenesis, 34, pp.1343~1351 (2013)
- Liu B, "Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation", Autophagy, 10, pp.416~430 (2014)
- Zhang Y, "HBx-associated long non-coding RNA activated by TGF-β promotes cell invasion and migration by inducing autophagy in primary liver cancer", Int J Oncol, 56, pp.337~347 (2020)
- Luo MX, "Autophagy mediates HBx-induced nuclear factor-κB activation and release of IL-6, IL-8, and CXCL2 in hepatocytes", J Cell Physiol, 230, pp.2382~2389 (2015)
- Fu S, "Crosstalk between hepatitis B virus X and high-mobility group box 1 facilitates autophagy in hepatocytes", Mol Oncol, 12, pp.322~338 (2018)
- García-Aranda M, "Bcl-2 inhibition to overcome resistance to chemo-and immunotherapy", Int J Mol Sci, 19, pp.3950~ (2018)
- Thomas S, "Targeting the Bcl-2 family for cancer therapy", Expert Opin Ther Targets, 17, pp.61~75 (2013)
